The abstract is read at the publisher; the summary is JClub's.
MOSPD3 anchors ATG2A at the ER by having its MSP domain bind an FFNT motif near ATG2A’s N terminus, defining the ER end of the bridge.
- Why it matters: The phagophore side of the ATG2A/ATG2B lipid-transfer bridge is known, but how the ER end is positioned and stabilized was unclear.
- What they did: The study identified MOSPD3 as an ER receptor for ATG2A, showing MSP-domain capture of the FFNT motif near ATG2A’s N terminus, while ATG2B recruitment is redundant via MOSPD1 and MOSPD3.
- The result: This receptor-based anchoring at the ER end clarifies how the bridge is organized and enables new questions about its regulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.